Idioma:

Management of hypertension: summary of NICE guidance

Krause, Taryn ; Lovibond, Kate ; Caulfield, Mark ; McCormack, Terry ; Williams, Bryan

BMJ, 2011-08, Vol.343 (7821), p.474-476 [Periódico revisado por pares]

England: British Medical Journal Publishing Group

Texto completo disponível

Citações Citado por

Enviar para

Título:
Management of hypertension: summary of NICE guidance
Autor: Krause, Taryn ; Lovibond, Kate ; Caulfield, Mark ; McCormack, Terry ; Williams, Bryan
Assuntos: Adult ; African Continental Ancestry Group ; Aged ; Aged, 80 and over ; Ambulatory blood pressure monitoring ; Angiotensin converting enzyme inhibitors ; Angiotensin Receptor Antagonists - therapeutic use ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Antihypertensive Agents - therapeutic use ; Antihypertensives ; Bias ; Blood pressure ; Blood Pressure Monitoring, Ambulatory ; Calcium channel blockers ; Calcium Channel Blockers - therapeutic use ; Cardiovascular disease ; Cardiovascular diseases ; Case management ; Cost-Benefit Analysis ; Diabetes ; Diuretics ; Dosage ; Drug Therapy, Combination ; Female ; Health care ; Health education ; Humans ; Hypertension ; Hypertension - diagnosis ; Hypertension - drug therapy ; Kidney diseases ; Male ; Middle Aged ; PRACTICE ; Practice Guidelines as Topic ; Primary care ; Quality ; Recommendations ; Risk Assessment ; Substance abuse treatment ; United Kingdom
É parte de: BMJ, 2011-08, Vol.343 (7821), p.474-476
Notas: This is one of a series of BMJ summaries of new guidelines based on the best available evidence; they highlight important recommendations for clinical practice, especially where uncertainty or controversy exists.
href:bmj-343-bmj-d4891.pdf
istex:55E500CDD2668757530521A5D8858B3F42764ED8
ArticleID:krat896670
ark:/67375/NVC-6RFJS62L-5
local:bmj;343/aug25_2/d4891
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-2
ObjectType-Feature-3
content type line 23
Descrição: (Updated recommendation) [Based on systematic reviews and meta-analyses of low quality observational and low to high quality randomised controlled trials; prognostic studies determined to be at low risk of bias; and a blood pressure equivalence study of low quality] Offer antihypertensive drug treatment to people of any age with stage 2 hypertension (an average ambulatory or home blood pressure of >=150/95 mm Hg; a clinic blood pressure >=160/100 mm Hg) irrespective of the presence of target organ damage, cardiovascular disease, renal disease, or the 10 year risk of cardiovascular disease. (Updated recommendation) [Based on moderate to very low quality evidence from randomised controlled trials and on the experience and opinion of the GDG] Step 4 (Resistant hypertension) If clinic blood pressure remains higher than 140/90 mm Hg after treatment with the optimal or best tolerated doses of the drug combination mentioned in step 3 (an ACE inhibitor or an ARB combined with a calcium channel blocker and a diuretic), regard this as resistant hypertension, and consider adding a fourth antihypertensive drug and/or seeking expert advice. (Updated recommendation) [Based on systematic reviews of very low to moderate quality randomised controlled trials, and cost effectiveness evidence] For people identified as having a "white coat effect"-that is, a discrepancy of more than 20/10 mm Hg between clinic and average daytime ambulatory blood pressure or average home blood pressure measurements at the time of diagnosis-consider ambulatory or home blood pressure monitoring as an adjunct to clinic blood pressure measurements to monitor the response to antihypertensive treatment with lifestyle modification or drugs. (Updated recommendation) [Based on a systematic review and meta-analysis that included moderate and high quality randomised controlled trials] Overcoming barriers The recommendation that ambulatory blood pressure rather than clinic blood pressure measurements should be used to confirm the diagnosis of hypertension will have a profound impact on patient care by reducing the number who are incorrectly labelled as hypertensive and thus inappropriately prescribed antihypertensive treatment.
Editor: England: British Medical Journal Publishing Group
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Management of hypertension: summary of NICE guidance

Krause, Taryn ; Lovibond, Kate ; Caulfield, Mark ; McCormack, Terry ; Williams, Bryan

England: British Medical Journal Publishing Group

Buscando em bases de dados remotas. Favor aguardar.